Repurposing the power injectable peripherally inserted central catheter as a tunnelled,non-cuffed,centrally inserted central venous catheter in oncological patients for short- to mid-term vascular access: A pilot study

Abstract

Objectives:

Usual short- to mid-term vascular accesses for oncologic patients include the peripherally inserted central catheter and non-tunnelled centrally inserted central catheters, inserted in the supraclavicular or infraclavicular area. Peripherally inserted central catheters can be restrictive in active patients; supraclavicular non-tunnelled centrally inserted central catheters are not ideal in terms of exit site location and cosmesis, while infraclavicular non-tunnelled centrally inserted central catheters may be associated with puncture-related complications. In this pilot study, we have evaluated the off-label use of peripherally inserted central catheters as a tunnelled supraclavicular centrally inserted central catheter.

Methods:

Ten patients were recruited for this prospective study. A non-cuffed, power injectable peripherally inserted central catheter was inserted via a short subcutaneous tunnel into the internal jugular vein using the peel-away sheath and introducer as a tunneller. Puncture wounds were closed with tissue glue. Patients were followed up for comfort scores, dwell time and complications.

Results:

The median dwell time was 94 days (mean of 113 days). One catheter was removed due to systemic fungemia, resulting in an acceptable complication rate of 0.97 per 1000 catheter days.Mean patient-reported comfort scores was 16 (out of 20). Pressurised injections for computer tomography imaging were performed in five patients without complications.

Conclusion:

Despite limited numbers, this method appears to be safe and well accepted with low complication rates. This modified vascular access is low profile, easily concealed, readily removable and compatible with pressure injector and uses a commonly found catheter in a modified fashion. Larger prospective trials will be needed to ascertain if it can be a standard of care for oncological patients.

Keywords

Oncology central venous catheter peripherally inserted central catheter novel technique

Get full access to this article

View all access options for this article.

References

Gallieni

Pittiruti

Biffi

. Vascular access in oncology patients. CA Cancer J Clin 2008; 58(6): 323–346.

Hentrich

Schalk

Schmidt-Hieber

, et al. Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology. Ann Oncol 2014; 25(5): 936–947.

Pittiruti

Ultrasound guided central vascular access in neonates, infants and children. Curr Drug Targets 2012; 13(7): 961–969.

Pittiruti

The ‘off-label’ use of PICCs. In: Sandrucci

Mussa

(eds) Peripherally inserted central venous catheters. Berlin: Springer, 2014, pp. 127–144.

Pittiruti

Emoli

Tunneling: the new frontier of central venous access devices. J Assoc Vasc Access 2016; 4(21): 261.

Pittiruti

Scoppettuolo

The GAVeCeLT manual of PICC and midlines. Milano: EDRA, 2017.

Lingegowda

Gehani

Sen

, et al. Centrally inserted tunnelled peripherally inserted central catheter: off-label use for venous access in oncology patients. J Vasc Access. 2020; 21(5): 773–777.

Lawson

Zealley

IA.

Adult ‘PICC’ device may be used as a tunnelled central venous catheter in children. Cardiovasc Intervent Radiol 2018; 41(4): 645–652.

Bernasconi

Zanaboni

Dato

, et al. Atypical use of PICC in infants and small children: a unicentric experience. J Vasc Access 2017; 18(6): 535–539.

10.

Kim

Shim

Lee

, et al. Impact of subcutaneous tunnels on peripherally inserted catheter placement: a multicenter retrospective study. Eur Radiol 2019; 29(5): 2716–2723.